Jubilant is a preferred partner of choice across the globe for innovator and generic pharmaceutical companies. Jubilant API business has prominent presence in markets such as North America, South America, Europe, Japan, APAC (Asia Pacific) and Middle East.
Jubilant offers one of the broadest portfolio comprising of more than 90 different APIs from various therapeutic categories like CNS, CVS, anti-infective, anti-diabetic etc.
-
Proven expertise to operate large scale chemical operations, which is key to better cost efficiencies
-
Global leaders in Carbamazepine, Oxcarbazepine, Pinaverium, Risperidone, Valsartan etc.
-
Diversified & large external customer base to drive growth across multiple regions
-
Business sustainability & supply assurance from backward integration of key APIs
-
Best in Class quality compliance, with excellent track records on successful multiple inspections by various regulatory bodies such as
US FDA, Health Canada, ANSM-France, ANVISA- Brazil, TGA- Australia, PMDA- Japan, COFEPRIS-Mexico and KFDA
-
A PI manufacturing site spans over an area of 2,67,000 square mts. with 33% built-up area; 6 large scale manufacturing blocks and a pilot plant; 170 reactors having volumetric capacity of 760 KL and 18 clean rooms
-
World class API R&D team comprises of more than 150 synthesis & analytical scientists including PhDs; Expertise in complex chemistries such as Chiral separation, Low Temp reactions, Bio-transformation, Stereo-selective synthesis, continuous flow reactions; equipped with latest analytical instruments such as LC HRMS, NMR, XRD, LCMS, etc. Analytical expertise in polymorphic characterization and contamination, Genetoxic & Carry over studies, Impurity profiling etc.
-
Dedicated DoE/QbD cell for bringing quality and process robustness during the product development